Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference

About this update from Outset Medical, Inc.

[{"type":"text","content":" SAN JOSE, Calif.--(BUSINESS WIRE)--\nOutset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 at 11:55am PT / 2:55pm ET.\n\nA live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.\n\nAbout Outset Medical, Inc.\n\nOutset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220830005061/en/\n\nJim Mazzola\nVice President, Investor Relations\[email protected]\n\nBrian Johnston\nGilmartin Group\n(332) 895-3222\[email protected]\n\nSource: Outset Medical, Inc.","length":3146,"tagName":"div"}]

More updates from Outset Medical, Inc.